Welcome to our dedicated page for Rentokil Initial Plc SEC filings (Ticker: RTO), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The SEC filings page for Rentokil Initial plc (NYSE: RTO) provides access to the company’s U.S. regulatory disclosures, including its annual report on Form 20-F and current reports on Form 6-K. As a foreign private issuer and UK-listed company, Rentokil Initial uses these filings to share information with U.S. investors about its global pest control, hygiene and wellbeing operations.
Form 20-F contains detailed information about the group’s business activities, risk factors, governance and financial reporting. For a company operating in around 90 countries and employing more than 60,000 people, this document is a key resource for understanding the structure and scope of its pest control and hygiene services, as well as its North American operations under the Rentokil Terminix brand.
Form 6-K current reports are used to furnish important information that Rentokil Initial releases in other markets. Examples in the available data include notifications of major shareholdings, directorate changes and announcements that the Annual Report and Financial Statements and AGM notices have been filed with the UK Financial Conduct Authority and made available via the National Storage Mechanism. Some 6-K filings also cover matters such as director and related party share dealings in the company’s American Depositary Shares.
On Stock Titan, these filings are updated as they are released through EDGAR and can be paired with AI-powered summaries to help explain complex sections in clearer language. This can be particularly useful when reviewing topics such as major shareholder notifications, governance changes or the structure of Rentokil Initial’s ADS programme, where each ADS represents five ordinary shares. The filings page is therefore a central reference point for investors and researchers seeking a regulatory view of RTO’s global business services operations.
Rentokil Initial plc has reported a change in a major shareholding by BlackRock, Inc.. BlackRock now holds a total of 12.51% of Rentokil Initial’s voting rights, equivalent to 316,885,253 voting rights.
The position consists of 10.05% of voting rights attached to ordinary shares and a further 2.46% held through financial instruments such as American Depositary Receipts, securities lending and derivatives. The total stake increased slightly from a previously notified 12.33%, indicating a modest rise in BlackRock’s exposure to the company.
Rentokil Initial plc reported that its Chair, Richard Solomons, who is classified as a Person Discharging Managerial Responsibility, bought additional shares in the company. On 26 March 2026, he purchased 21,100 ordinary shares at a price of £4.635902 per share, for a total consideration of £97,817.53. The transaction involved ordinary shares of 1p each, traded on the London Stock Exchange (XLON), and was disclosed in line with Article 19 of the UK Market Abuse Regulation.
Rentokil Initial plc has made its Annual Report and meeting materials for the year ended 31 December 2025 available to investors. The company has filed its Annual Report and Financial Statements 2025, the Notice of the 2026 Annual General Meeting (AGM), and the Proxy Form with the UK Financial Conduct Authority.
The Annual Report 2025 and Notice of 2026 AGM are available on the company’s website, and the AGM will be held and broadcast from the company’s Compass House offices in Crawley on 7 May 2026 at 2:00pm. Rentokil Initial has also filed its Annual Report on Form 20-F with the US Securities and Exchange Commission, accessible via the SEC and company websites.
Rentokil Initial plc filed its 2025 Form 20‑F, providing a comprehensive overview of its global pest control and hygiene operations. The group prepares financials under IFRS and lists American Depositary Shares on the NYSE, with each ADS representing five ordinary shares.
As of 31 December 2025, Rentokil Initial had 2,526,039,885 ordinary shares outstanding, 63,388 colleagues and 2,081 facilities across 90 countries. The company highlights an acquisition‑led growth strategy, noting 36 businesses acquired in 2025 and the disposal of its French Workwear business completed on 30 September 2025.
Extensive risk disclosures cover integration challenges, heavy reliance on skilled labour, inflation and macroeconomic pressures, ESG expectations, and cyber security. The group reports ten cyber security incidents in 2025, all handled without material business impact. It also details substantial termite‑related damage claims, with additional provisions of $201 million and a closing provision of $384 million, alongside total outstanding indebtedness of approximately $6.1 billion and related covenant and ratings risks.
Rentokil Initial plc reported that Non-Executive Director and Person Discharging Managerial Responsibility Sally Johnson bought ordinary shares in the company. On 16 March 2026, she purchased 2,676 ordinary shares at a price of £4.828995 per share, for a total of £12,922.39.
The shares are ordinary shares of 1p each, identified by ISIN GB00B082RF11, and the transaction took place on the London Stock Exchange (XLON). The disclosure is made in line with Article 19 of the UK Market Abuse Regulation.
Rentokil Initial plc reported that investor BlackRock, Inc. has crossed a major shareholding threshold, with a total of 12.330000% of the company’s voting rights. This represents 312131771 voting rights in aggregate.
The position includes 9.910000% of voting rights attached to ordinary shares, representing 250562761 voting rights. A further portion is held through financial instruments, including American Depository Receipts and securities lending positions, plus contracts for difference and equity-linked notes, giving BlackRock exposure to additional voting rights in Rentokil Initial.
Rentokil Initial plc reported a notification of major holdings from GIC Private Limited following a change in the nature of its holding due to securities lending. GIC now holds 3.016405% of Rentokil’s voting rights through shares and 0.170558% through lent securities, giving a total of 3.186963% voting rights attached to 80,503,946 shares. This compares with a previous total interest of 3.253885%. The position includes both direct and indirect shareholdings structured through various GIC investment subsidiaries based in Singapore and the United Kingdom.
Rentokil Initial plc reports that the Samuel J. Mitchell, Jr. Revocable Trust, a person closely associated with non-executive director Samuel Mitchell, purchased 3,225 American Depositary Shares at USD 30.9598 each, for a total of USD 99,845.36, on the New York Stock Exchange on March 9 2026.
Each ADS represents five ordinary shares of one pence each in the company’s capital, so this transaction increases the trust’s indirect economic exposure to Rentokil Initial shares.
Rentokil Initial plc reported that CEO Designate Mike (Michael) Duffy, together with his Person Closely Associated, Laura Duffy, purchased 16,000 American Depositary Shares (ADSs) of the company on 9 March 2026 on the New York Stock Exchange.
The ADSs were bought at a price of USD 30.9584 per ADS, for an aggregate consideration of USD 495,334.40. Each ADS represents five ordinary shares of one pence each, and the purchase was made into a joint brokerage account held by Mike and Laura Duffy.